MedPeer, Inc. (6095) AI Stock Analysis

• Market Cap: ¥16.11B
• Dividend Yield: 0.61%
• Average Volume (3M): 442.16K
• Price to Earnings (P/E): 9.3
• Beta (1Y): 1.12
• Revenue Growth: -12.13%
• EPS Growth: 291.07%
• Country: JP
• Employees: 489
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 4.53
• Shares Outstanding: 22,010,330
• 10 Day Avg. Volume: 376,580
• 30 Day Avg. Volume: 442,163
• PEG Ratio: -0.92
• Price to Book (P/B): 3.68
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 40.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 74 Outperform
• Price Target: ¥782.00 ▲(8.61%Upside)

MedPeer, Inc. demonstrates robust financial performance with strong revenue growth and efficient cost management. The low P/E ratio suggests undervaluation, enhancing the stock's appeal. However, the technical analysis indicates potential risks of a pullback due to overbought conditions. Cash flow management requires attention to sustain long-term growth.

MedPeer, Inc. Business Overview & Revenue Model

Company Description

MedPeer, Inc. (6095) operates primarily in the healthcare sector, focusing on providing a platform for doctors to share medical insights and information. The company offers a peer-to-peer online community where physicians can discuss clinical cases, share experiences, and access a vast repository of medical knowledge. MedPeer aims to enhance the quality of medical care by facilitating the exchange of professional knowledge among healthcare providers.

How the Company Makes Money

MedPeer, Inc. generates revenue through a combination of membership fees from participating healthcare professionals and advertising fees from pharmaceutical companies and other entities targeting medical professionals. The company also offers premium services and features to its users, which contribute to its revenue. Additionally, partnerships with healthcare institutions and research organizations may offer further revenue opportunities through collaborative projects and data-driven studies.

MedPeer, Inc. Financial Statement Overview

Summary

MedPeer, Inc. exhibits solid financial performance with strong revenue and profit growth, efficient cost management, and low leverage. The income statement and balance sheet reflect overall financial health. However, cash flow management needs attention to support long-term growth and operational resilience.

Income Statement

MedPeer, Inc. demonstrates strong revenue growth with a notable increase from 2022 to TTM 2024. The gross profit margin is robust, indicating efficient cost management. While the net profit margin is healthy, the slight decline in EBIT margin suggests increasing operational expenses. Overall, the income statement reflects a solid financial performance with room for margin improvement.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio, indicating financial stability and low leverage risk. The equity ratio highlights a solid asset base supported by equity. Return on Equity (ROE) is commendable, showing efficient use of shareholder funds. However, the slight increase in total liabilities requires monitoring to ensure continued financial health.

Cash Flow

Cash flow analysis shows mixed results. The operating cash flow has significantly increased, demonstrating enhanced cash-generating capability. Free cash flow has grown, but the absence of recent data limits a complete trend analysis. The ratio of operating cash flow to net income is favorable, suggesting good cash conversion. Continued focus on sustaining cash flow growth is necessary.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
14.32B	14.95B	14.54B	8.45B	7.44B	5.31B
	Gross Profit
6.48B	6.87B	6.87B	5.03B	4.85B	3.51B
	EBIT
1.32B	1.29B	1.12B	1.06B	1.78B	1.10B
	EBITDA
1.72B	3.01B	1.87B	1.30B	1.98B	1.27B
	Net Income Common Stockholders
1.52B	1.48B	617.68M	812.39M	1.29B	725.97M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
7.13B	7.28B	5.39B	6.14B	5.70B	4.70B
	Total Assets
15.36B	15.55B	15.16B	9.35B	8.54B	7.13B
	Total Debt
3.04B	3.16B	3.81B	179.12M	136.32M	202.90M
	Net Debt
-4.09B	-4.12B	-1.58B	-5.96B	-5.57B	-4.50B
	Total Liabilities
5.67B	6.10B	6.57B	1.49B	1.56B	1.55B
	Stockholders Equity
9.69B	9.45B	8.30B	7.59B	6.71B	5.35B
Cash Flow		Free Cash Flow
0.00	1.63B	494.10M	691.01M	1.11B	758.87M
	Operating Cash Flow
0.00	1.89B	600.07M	853.23M	1.36B	930.30M
	Investing Cash Flow
0.00	1.27B	-5.01B	-422.88M	-345.39M	-469.23M
	Financing Cash Flow
0.00	-1.27B	3.67B	7.08M	-15.44M	1.11B

MedPeer, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 720.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6095, the sentiment is Positive. The current price of 720 is below the 20-day moving average (MA) of 728.00, above the 50-day MA of 560.82, and above the 200-day MA of 530.14, indicating a bullish trend. The MACD of 47.93 indicates Positive momentum. The RSI at 66.02 is Neutral, neither overbought nor oversold. The STOCH value of 31.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6095.

MedPeer, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥19.08B	17.42		2.10%	12.51%	9.68%
6095	74 Outperform	¥16.11B	9.30		0.61%	-12.13%	291.07%
4320	67 Neutral	¥10.35B	21.63		2.77%	9.21%	-20.04%
3939	65 Neutral	¥19.77B	20.19		1.57%	17.20%	20.25%
Sector *	54 Neutral	$5.41B	3.27	-45.10%	3.29%	16.81%	0.02%
4263	45 Neutral	¥11.01B	―		―	-79.38%	-1239.83%
3902	43 Neutral	¥15.75B	4,465.71		1.60%	-7.98%	-181.00%

MedPeer, Inc. Corporate Events

MedPeer Announces Amendments to MBO Tender Offer Notice

MedPeer, Inc. announced amendments to its previously published notice regarding the implementation of a Management Buyout (MBO) and a recommendation to tender shares. The amendments clarify the intentions of Mr. Yo Iwami, a significant shareholder, to release collateralized shares and participate in the tender offer. The company plans to finance the tender offer through a bank loan from MUFG Bank and an equity investment, with the acquired shares and certain company assets pledged as collateral.

MedPeer, Inc. Announces Management Buyout and Delisting Plans

MedPeer, Inc. has announced a management buyout (MBO) involving a tender offer by NMT, Inc. to purchase its common shares, with the intention of taking the company private and delisting its shares. The board has expressed support for the tender offer, recommending shareholders to tender their shares, while leaving stock acquisition rights holders to decide independently. This move is expected to retract MedPeer’s plan for compliance with continued listing criteria, impacting its market presence and shareholder dynamics.

NMT, Inc. Launches Tender Offer for MedPeer, Inc. Shares

NMT, Inc. has announced a tender offer to acquire all shares of MedPeer, Inc., aiming to delist the company from the Tokyo Stock Exchange. This move, characterized as a management buyout, will see NMT’s founder, Yo Iwami, maintaining involvement in MedPeer’s operations, potentially impacting stakeholders by consolidating control and potentially reshaping the company’s strategic direction.

MedPeer, Inc. Reports Decline in Financial Results Amidst Market Challenges

MedPeer, Inc. reported a decline in its consolidated financial results for the six months ended March 31, 2025, with net sales and operating profits experiencing significant decreases compared to the previous year. Despite the downturn in sales, the company saw a substantial increase in profit attributable to owners of the parent, indicating improved efficiency or cost management. The forecast for the fiscal year ending September 30, 2025, suggests further declines in sales and profits, posing challenges for the company’s future growth and market positioning.

MedPeer, Inc. Supports Tender Offer and Plans Delisting

MedPeer, Inc. has announced its support for a tender offer by NMT, Inc. to purchase its common stock and stock acquisition rights, with plans to delist the company shares following the offer. This decision leads to the retraction of MedPeer’s previously announced compliance plan for continued listing criteria, indicating a strategic shift in the company’s market approach and potential implications for its shareholders.

MedPeer Revises Dividend Forecast Amid Tender Offer Plans

MedPeer, Inc. announced a revision to its dividend forecast for the fiscal year ending September 2025, deciding not to distribute year-end dividends. This decision aligns with the company’s support for a tender offer by NMT, Inc., which aims to take MedPeer private and delist its shares. The tender offer price assumes no year-end dividends, reflecting a strategic shift in the company’s financial planning and shareholder returns policy.